Skip to content
Menu

SuperCom Ltd. SPCB

Full chart Compare
Set alert

Price alert · SPCB

All alert types
6.41 USD -0.29 (-4.33%)

Regular-session close

6.19 -0.22 -3.43%

After hours · Nov 20, 4:00 PM ET

6.33 Day range 6.77
6.00 52-week range 12.87
YTD
-29.17%
1 year
-20.67%

Discussion (46)

VICKY HANUKA SPCB 3 years ago #2

?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi

-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for 
$1.0 billion upfront 
-- PTC Therapeutics has option to sell rest of royalty for up to $500 
million; Royalty Pharma has option to buy half of rest of royalty for up 
to $250 million 
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth 
(non-GAAP) 
-- Royalty Pharma to host conference call today, Thursday, October 19 at 
9:00am EDT 
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

Jansen SPCB 5 years ago #6

Could be a hidden gem if newer people find it and buy solely because it’s cheap?

FDBullish SPCB 5 years ago #7

I guess this stock’s is understand it should be around $12 per share

JNJ q SPCB 6 years ago #10

Lionmaster has so much pull and following! Jump on before it’s too late.

Sign in to join the discussion